StonvexLoading…
StonvexStonvexStonvexCore line items from CHGG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $50.74M | $63.26M | $376.91M | $304.25M | $226.51M |
Operating Income | Not available | $-1.04M | $-116.86M | $-82.58M | $-65.46M |
Net Income | Not available | $228.00K | $-103.42M | $-70.62M | $-53.15M |
EPS (Diluted) | $-0.05 | $0.00 | $-0.96 | $-0.66 | $-0.50 |
Total Assets | Not available | $244.10M | $278.01M | $378.27M | $404.45M |
Total Liabilities | Not available | $122.96M | $158.39M | $232.22M | $246.60M |
Cash & Equivalents | Not available | $33.53M | $31.15M | $38.18M | $36.83M |
Free Cash Flow OCF − CapEx | Not available | $3.06M | $-12.63M | $2.85M | $3.79M |
Shares Outstanding | Not available | 111.84M | 110.99M | 108.78M | 107.82M |